Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 19 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				20 to 75				Pharmaceutical / Industry				01023010 / TOP-003 NCT00284258

Last Modified: 7/5/2007 First Published: 9/9/2005


2.		Phase III Randomized Study of Neoadjuvant S-1 and Cisplatin in Patients With Potentially Resectable Stage III Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				20 and over				Other				KYUH-UHA-GC04-03 NCT00182611


3.		A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				20 to 75				Other				JCOG9912 C000000062, NCT00142350


4.		Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				Pharmaceutical / Industry				SC101 NCT00202969


5.		IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Temporarily closed				18 to 75				Other				HGCSG0601 IFOX study, NCT00316745


6.		S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Treatment				Temporarily closed				18 and over				Pharmaceutical / Industry				EFC10203 S-1 - FI, NCT00602745


7.		Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				Pharmaceutical / Industry				TPU-S1101; ID02-694 NCT00072787


8.		Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Temporarily closed				20 to 75				Other				HGCSG0405 GEMS-1, NCT00209677


9.		Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				20 to 74				Other				SCC-07-01 NCT00524706

Last Modified: 6/1/2000 First Published: 9/1/1999


10.		Phase II Study of S-1 in Patients With Locally Advanced, Metastatic, or Unresectable Gastric or Colorectal Cancer (Summary Last Modified 06/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				EORTC-16972C/G TAIHO-EORTC-16972C/G

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute